Device brand name · 80mea
Lc Pca Hospira Medne: medical device reports filed with FDA
161 reports name it, 2011–2015. Manufacturer given most often on reports: Hospira Costa Rica. Product code MEA.
- 161
- device reports naming the brand
- 0% of all MAUDE reports · about 11 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 97.5%
- classified as malfunction
- 95.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
161 medical device reports received by FDA name the brand "Lc Pca Hospira Medne" (80mea); the manufacturer given most often on reports is Hospira Costa Rica; received from April 2011 to May 2015. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (97.5%) and injury (2.5%); across all pump, infusion, pca reports (product code MEA) death is recorded in 0.7% and malfunction in 95.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device inoperable (61.5%), insufficient flow or under infusion (7.5%) and failure to deliver (3.7%). The patient problems coded most often are no patient involvement, lethargy and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Lc Pca Hospira Medne was received in the five years to August 2026; the latest was received in May 2015.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 32,877 reports carrying product code MEA. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device inoperablethe device could not be used | 99 | 61.5% | 0.5% |
| Insufficient flow or under infusion | 12 | 7.5% | 1.6% |
| Failure to deliverthe device did not deliver the dose or item | 6 | 3.7% | 1.3% |
| Excess flow or over-infusion | 5 | 3.1% | 4.5% |
| Loss of powerthe device lost power | 5 | 3.1% | 0.4% |
| No audible alarm | 5 | 3.1% | 0.7% |
| Failure to sense | 2 | 1.2% | 2.7% |
| Occlusion within devicethe device blocked | 2 | 1.2% | 0.6% |
| Self-activation or keying | 2 | 1.2% | 0.6% |
| Thermal decomposition of device | 2 | 1.2% | 0% |
| Battery problema problem with the battery | 1 | 0.6% | 0.3% |
| Bent | 1 | 0.6% | 0% |
| Breakthe device broke | 1 | 0.6% | 20.1% |
| Device alarm system | 1 | 0.6% | 5.4% |
| Inaccurate delivery | 1 | 0.6% | 3.2% |
| Incorrect software programming calculations | 1 | 0.6% | 0.7% |
| Overheating of device | 1 | 0.6% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 77 | 47.8% |
| Lethargysluggishness | 1 | 0.6% |
| Painpain, site not specified | 1 | 0.6% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Lc Pca Hospira Medne | Product code MEA | All MAUDE reports |
|---|---|---|---|
| Reports | 161 | 32,877 | 26,136,888 |
| Share of that pool | — | 0.5% | 0% |
| Classified as death, per 1,000 reports | 0 | 7 | 9 |
| Classified as injury | 2.5% | 2.6% | 36.2% |
| Classified as malfunction | 97.5% | 95.6% | 62.3% |
| Filed by the manufacturer | 100% | 96.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MEA
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Alaris System | 422,501 | 33,692 | 0% |
| 8120 Alaris Pca | 6,258 | 0 | 0% |
| CADD Solis HPCA Pump | 2,846 | 1,183 | 0.1% |
| CADD-Solis Ambulatory Infusion Pump | 1,974 | 151 | 0.3% |
| Ipump Pain Management System | 1,018 | 0 | 0.5% |
| Alaris Pca | 1,707 | 0 | 0.1% |
| Lifecare Pca Plus Infuser | 757 | 0 | 6.9% |
| CADD-Solis HCPA Pump | 735 | 33 | 0% |
| CADD-Solis HPCA Pump | 672 | 224 | 0% |
| Cadd-Legacy Pca Ambulatory Infusion Pump | 436 | 8 | 1.1% |
| CADD Solis HPCA Pumps | 391 | 145 | 0% |
| Pca Empty Sterile | 349 | 0 | 0% |
| Cadd | 10,811 | 9 | 0.1% |
| CADD Legacy PCA Pump | 349 | 71 | 0% |
| Alaris Pca Module | 879 | 0 | 3.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Lc Pca Hospira Medne reports
How many FDA reports name Lc Pca Hospira Medne?
161 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (97.5%) and injury (2.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device inoperable (61.5%), insufficient flow or under infusion (7.5%), failure to deliver (3.7%), excess flow or over-infusion (3.1%) and loss of power (3.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Lc Pca Hospira Medne was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.